You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

hsct

Showing 1 - 25 of 1,779
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

EBV Infection After Allogenic HSCT Trial in Beijing (EBV-TCR-T cells)

Recruiting
  • EBV Infection After Allogenic HSCT
  • EBV-TCR-T cells
  • Beijing, Beijing, China
    Chinese PLA General Hospital
Nov 3, 2023

The Effecacy and Safety of Humanized CD25 Antibody in aGVHD Prophylaxis Among Elderly Patients After HID-HSCT Trial (CD25

Not yet recruiting
  • The Effecacy and Safety of Humanized CD25 Antibody in aGVHD Prophylaxis Among Elderly Patients After HID-HSCT
  • CD25 prophylaxis
  • (no location specified)
Jun 20, 2023

Myeloid Leukemia, MDS Trial (IFN-?)

Not yet recruiting
  • Myeloid Leukemia
  • Myelodysplastic Syndromes
  • (no location specified)
Nov 15, 2023

Hematopoietic Stem Cell Transplantation, Hematologic Malignancy Trial (CliniMACS®)

Not yet recruiting
  • Hematopoietic Stem Cell Transplantation
  • Hematologic Malignancy
  • CliniMACS®
  • (no location specified)
Oct 17, 2023

Tumor, Caregivers Trial run by the National Institutes of Health Clinical Center (CC) (Sham VR, Active VR)

Not yet recruiting
  • Neoplasm
  • Caregivers
  • Sham VR
  • Active VR
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jun 26, 2023

Hematologic Malignancy, Stem Cell Transplant Complications Trial in Beijing (Beijing protocol)

Recruiting
  • Hematologic Malignancy
  • Stem Cell Transplant Complications
  • Beijing protocol
  • Beijing, Beijing, China
    Deparment of Hematology, Peking University People's Hospital
Jun 19, 2023

Tacrolimus Blood Concentration and Transplant-related Outcomes

Recruiting
  • Graft Vs Host Disease
  • +2 more
  • TAC C/D ratio
  • Trieste, Italy
    IRCCS Burlo Garofolo
Oct 6, 2023

Acute Leukemia Trial in Suzhou (mitoxantrone liposome, ATG)

Recruiting
  • Acute Leukemia
  • mitoxantrone liposome
  • ATG
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Feb 13, 2023

Allogenic Stem Cell Transplantation Trial (SAR445419)

Not yet recruiting
  • Allogenic Stem Cell Transplantation
  • (no location specified)
Feb 13, 2023

Immune Reconstitution After Allo-HSCT and Blinatumomab

Not yet recruiting
  • Leukemia, Lymphoid
  • (no location specified)
Oct 3, 2023

Hematopoietic Stem Cell Transplantation, Bone Marrow Transplantation Trial (yoga or gentle massage plus standard treatment for

Not yet recruiting
  • Hematopoietic Stem Cell Transplantation
  • Bone Marrow Transplantation
  • yoga or gentle massage plus standard treatment for HSCT
  • (no location specified)
Nov 1, 2023

Cytomegalovirus Infection Outcomes Among Hematopoietic Stem Cell

Not yet recruiting
  • Cytomegalovirus (CMV)
    • (no location specified)
    Oct 11, 2022

    Stress, Psychological, Caregivers Trial run by the National Institutes of Health Clinical Center (CC) (Stress reduction

    Completed
    • Stress, Psychological
    • Caregivers
    • Stress reduction intervention
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 13, 2023

    Allogeneic Hematopoietic Stem Cell Transplantation, Acute Lymphoblastic Leukemia Trial in Suzhou (VEN+AZA+Modified BUCY)

    Recruiting
    • Allogeneic Hematopoietic Stem Cell Transplantation
    • Acute Lymphoblastic Leukemia
    • VEN+AZA+Modified BUCY
    • Suzhou, Jiangsu, China
      The First Affiliated Hospital of Soochow University
    Apr 10, 2023

    Acute Myeloid Leukemia Trial in Xuzhou (allogenic NK cells)

    Recruiting
    • Acute Myeloid Leukemia
    • allogenic NK cells
    • Xuzhou, Jiangsu, China
      The Affiliated Hospital of Xuzhou Medical University
    Feb 23, 2023

    Prophylactic HQP1351 Therapy, Third Generation TKI Trial in Guanzhou (HQP1351( Olverembatinib dimesylate))

    Withdrawn
    • Prophylactic HQP1351 Therapy
    • Third Generation TKI
    • HQP1351( Olverembatinib dimesylate)
    • Guanzhou, China
      Department of Hematology, Nanfang Hospital, Southern Medical Uni
    Jan 16, 2023

    Hematopoietic Stem Cell Transplant (HSCT), Bronchiolitis Obliterans (BO) Trial in Cincinnati (Ruxolitinib)

    Recruiting
    • Hematopoietic Stem Cell Transplant (HSCT)
    • Bronchiolitis Obliterans (BO)
    • Cincinnati, Ohio
      Cincinnati Children's Hospital Medical Center
    Aug 6, 2022

    Allogeneic Hematopoietic Stem Cell Transplantation, Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Suzhou

    Recruiting
    • Allogeneic Hematopoietic Stem Cell Transplantation
    • +2 more
    • VEN+AZA+Modified BUCY
    • Suzhou, Jiangsu, China
      The First Affiliated Hospital of Soochow University
    Apr 10, 2023

    MPS-IH (Hurler Syndrome) Trial in Worldwide (Experimental: OTL-203, Active Comparator: Allo-HSCT)

    Not yet recruiting
    • MPS-IH (Hurler Syndrome)
    • Experimental: OTL-203
    • Active Comparator: Allo-HSCT
    • Oakland, California
    • +6 more
    Nov 27, 2023

    Brain Neuronal Networks, Chemosensory and Trigeminal Functions

    Recruiting
    • Hematopoietic Stem Cell Transplantation
      • Oslo, Norway
        University of Oslo
      Aug 21, 2023

      Leukemia Trial (Prehabilitation)

      Not yet recruiting
      • Leukemia
      • Prehabilitation
      • (no location specified)
      Dec 5, 2022

      Hematopoietic Malignancy, Relapse/Recurrence, Hematopoietic Stem Cell Transplantation Trial in Suzhou (Umbilical Cord Blood

      Recruiting
      • Hematopoietic Malignancy
      • +2 more
      • Umbilical Cord Blood Transplantation
      • Suzhou, Jiangsu, China
        The First Affiliated Hospital of Soochow university
      Nov 6, 2023

      The Prophylactic Value of Ruxolitinib for aGVHD in HSCT Recipients of AA Trial (Ruxolitinib 5 MG BID Oral Tablet)

      Not yet recruiting
      • The Prophylactic Value of Ruxolitinib for aGVHD in HSCT Recipients of AA
      • Ruxolitinib 5 MG BID Oral Tablet
      • (no location specified)
      Jun 13, 2023

      Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Hematopoietic Stem Cell Transplant (HSCT) Trial in Pittsburgh

      Active, not recruiting
      • Acute Myeloid Leukemia (AML)
      • +2 more
      • Reduced-Intensity Conditioning Regimen
      • Myeloablative Conditioning Regimen
      • Pittsburgh, Pennsylvania
        UPMC Children's Hospital of Pittsburgh
      Jan 4, 2023

      Leukemia, Myeloid, Acute, MDS, Hematopoietic Stem Cell Transplantation Trial in Shanghai (Venetoclax plus RIC)

      Not yet recruiting
      • Leukemia, Myeloid, Acute
      • +3 more
      • Venetoclax plus RIC
      • Shanghai, Shanghai, China
        Shanghai General Hospital
      Oct 12, 2022